Iron Deficiency Anemia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Age 20–40 years; 2.Gestational age 12–28 weeks; 3.Laboratory-confirmed mild to moderate iron deficiency anemia (Hb 70–109 g/L and SF < 30 µg/L); 4.Willing to participate in the study and provide written informed consent.
Exclusion criteria
Exclusion criteria: 1.Presence of recurrent vaginal bleeding; Acute infection or liver/kidney dysfunction (transaminase or serum creatinine > 2x upper limit of normal); 2.Definite diagnosis of thalassemia, aplastic anemia, chronic kidney disease, or autoimmune disease; 3.Intolerance or history of allergy to iron dextran oral solution; 4.Any other condition that, in the investigator's judgment, makes the subject unsuitable for participation in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pre-delivery Hb Level; | — |
Secondary
| Measure | Time frame |
|---|---|
| Incidence of Adverse Reactions; | — |
Countries
China
Contacts
The Third Affiliated Hospital of Guangzhou Medical University